In contrast, Dll4 haploinsufficiency and intermittent administration of sDll4 (3 times a week for 3.5 weeks) in RT2 mice significantly reduced tumor growth, but did not cause any vascular lesions in the liver or other vital organs such as heart, brain, lung, kidney, and intestine (data not shown). This evidence concerns the gene DLL4 and neoplasm.